In the pharmaceutical industry, Mebendazole 100 mg is a broad-spectrum benzimidazole anthelmintic (anti-worm medication). As a pharmacist and manufacturer, I classify this as a “luminal” agent, meaning it works primarily within the gastrointestinal tract to eradicate parasitic infestations with minimal systemic absorption into the patient’s bloodstream.

Primary Clinical Uses

Mebendazole is highly effective against a variety of intestinal helminthes. The 100 mg chewable or standard tablet is the gold standard for:

• Enterobiasis (Pinworm/Threadworm): The most common use, often requiring a single 100 mg dose followed by a second dose two weeks later to prevent reinfection.

• Ascariasis (Roundworm): Usually treated with 100 mg twice daily for three consecutive days.

• Hookworm Infections: Effective against both Ancylostoma duodenale and Necator americanus.

• Trichuriasis (Whipworm): Used to clear infections in the large intestine.

Mechanism of Action: Microtubule Inhibition

Mebendazole works by selectively interfering with the biological structure of the parasite.

Tubulin Binding: It binds to the $\beta$-tubulin protein of the parasite with high affinity.

Inhibition of Polymerization: This binding prevents the polymerization of tubulin into microtubules, which are essential for the worm’s cellular structure and nutrient transport.

Glucose Depletion: Without microtubules, the worm cannot absorb glucose (its primary energy source). This leads to the depletion of glycogen stores, resulting in the parasite’s immobilization and eventual death, after which it is expelled naturally through the stool.

The Manufacturer’s Perspective: Formulation & Export

From a production standpoint at a WHO-GMP facility like yours, Mebendazole 100 mg involves specific technical considerations:

• Chewable Tablet Technology: For pediatric export markets, we often formulate this as a chewable tablet with palatable flavors (like strawberry or orange). Ensuring the “mouthfeel” and “grittiness” are minimized is a key R&D goal for patient compliance.

• Poor Solubility (BCS Class II/IV): Mebendazole is practically insoluble in water. We utilize specific surfactants and micronization techniques to ensure that even though absorption is low, the drug remains active and distributed throughout the gut lumen.

   

• Stability for Global Trade: We utilize Alu-Alu or high-grade PVC/PVDC blister packaging to protect the product from moisture, ensuring a 36-month shelf life for export to Zone IVb regions (Africa and Southeast Asia), where helminthic infections are endemic.

• B2B & Dossier Support: This is a staple product for “National Deworming Programs” and NGO tenders. Our Mumbai facility provides full CTD/eCTD Dossiers to support international registration against the innovator (Vermox).